Learn how the FDA's 180-day exclusivity works for generic drug applicants, including Paragraph IV certifications, forfeiture risks, and upcoming regulatory changes.
Mar, 26 2026
Nov, 17 2025
Mar, 22 2025
Jan, 16 2026
Oct, 3 2025